- $9.08bn
- $9.65bn
- $2.91bn
- 97
- 25
- 93
- 82
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,900 | 2,496 | 2,246 | 2,383 | 2,915 |
Cost of Revenue | |||||
Gross Profit | 708 | 640 | 551 | 525 | 695 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,581 | 2,253 | 1,988 | 2,164 | 2,631 |
Operating Profit | 319 | 243 | 258 | 219 | 283 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 321 | 282 | 246 | 200 | 276 |
Provision for Income Taxes | |||||
Net Income After Taxes | 270 | 240 | 209 | 172 | 232 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 260 | 240 | 209 | 172 | 232 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 260 | 240 | 209 | 172 | 232 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.38 | 4.12 | 3.19 | 2.73 | 4.28 |
Dividends per Share |